ME Jul 2023 5.000 call
| Previous close | 0.1900 |
| Open | 0.1000 |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 5.00 |
| Expiry date | 2023-07-21 |
| Day's range | 0.1000 - 0.1900 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
- Motley Fool
3 Penny Stocks That Could Make You Filthy Rich
The current economic environment, however, has pushed several intriguing, innovation-oriented companies into penny stock territory. Although these names are still exceedingly high-risk, I think aggressive investors may want to consider buying shares of Precigen (NASDAQ: PGEN), Rigel Pharmaceuticals (NASDAQ: RIGL), and 23andMe Holding Company (NASDAQ: ME) right now. Read on to find out why these three low-priced equities might be a tremendous wealth escalator for patient shareholders.
- Simply Wall St.
Institutional investors own a significant stake of 37% in 23andMe Holding Co. (NASDAQ:ME)
If you want to know who really controls 23andMe Holding Co. ( NASDAQ:ME ), then you'll have to look at the makeup of...
- Yahoo Finance Video
Telehealth: ‘There’s a real opportunity’ for investment, 23andMe founder says
23andMe Co-Founder and CEO Anne Wojcicki sits down with Yahoo Finance’s Anjalee Khemlani at the HLTH conference to discuss the slowdown in growth, consolidation in the health care space, the company’s partnership with GSK, drug discovery, and more.
